Medical Care
Global Neuropathic Eye Pain Market Research Report 2025
- May 12, 25
- ID: 235031
- Pages: 82
- Figures: 83
- Views: 9
The global market for Neuropathic Eye Pain was valued at US$ 161 million in the year 2024 and is projected to reach a revised size of US$ 200 million by 2031, growing at a CAGR of 3.1% during the forecast period.
North American market for Neuropathic Eye Pain is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Neuropathic Eye Pain is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Neuropathic Eye Pain in Clinic is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Neuropathic Eye Pain include OKYO Pharma, Ocular Therapeutix, Inc., IACTA Pharmaceuticals, Inc., Sun Pharmaceutical Industries Ltd, Novartis AG, SALVAT, AbbVie Inc, Bausch &Lomb Incorporated, Kala Pharmaceuticals, Spectra Vision Care, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Neuropathic Eye Pain, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neuropathic Eye Pain.
The Neuropathic Eye Pain market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Neuropathic Eye Pain market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neuropathic Eye Pain companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
OKYO Pharma
Ocular Therapeutix, Inc.
IACTA Pharmaceuticals, Inc.
Sun Pharmaceutical Industries Ltd
Novartis AG
SALVAT
AbbVie Inc
Bausch &Lomb Incorporated
Kala Pharmaceuticals
Spectra Vision Care
AlconLaboratories
BRIM Biotechnology Inc
Segment by Type
Steroids
Antidepressants
Anticonvulsants
Opioids
Others
Segment by Application
Clinic
Hospital
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Neuropathic Eye Pain company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
North American market for Neuropathic Eye Pain is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Neuropathic Eye Pain is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Neuropathic Eye Pain in Clinic is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Neuropathic Eye Pain include OKYO Pharma, Ocular Therapeutix, Inc., IACTA Pharmaceuticals, Inc., Sun Pharmaceutical Industries Ltd, Novartis AG, SALVAT, AbbVie Inc, Bausch &Lomb Incorporated, Kala Pharmaceuticals, Spectra Vision Care, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Neuropathic Eye Pain, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neuropathic Eye Pain.
The Neuropathic Eye Pain market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Neuropathic Eye Pain market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neuropathic Eye Pain companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
OKYO Pharma
Ocular Therapeutix, Inc.
IACTA Pharmaceuticals, Inc.
Sun Pharmaceutical Industries Ltd
Novartis AG
SALVAT
AbbVie Inc
Bausch &Lomb Incorporated
Kala Pharmaceuticals
Spectra Vision Care
AlconLaboratories
BRIM Biotechnology Inc
Segment by Type
Steroids
Antidepressants
Anticonvulsants
Opioids
Others
Segment by Application
Clinic
Hospital
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Neuropathic Eye Pain company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neuropathic Eye Pain Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Steroids
1.2.3 Antidepressants
1.2.4 Anticonvulsants
1.2.5 Opioids
1.2.6 Others
1.3 Market by Application
1.3.1 Global Neuropathic Eye Pain Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Neuropathic Eye Pain Market Perspective (2020-2031)
2.2 Global Neuropathic Eye Pain Growth Trends by Region
2.2.1 Global Neuropathic Eye Pain Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Neuropathic Eye Pain Historic Market Size by Region (2020-2025)
2.2.3 Neuropathic Eye Pain Forecasted Market Size by Region (2026-2031)
2.3 Neuropathic Eye Pain Market Dynamics
2.3.1 Neuropathic Eye Pain Industry Trends
2.3.2 Neuropathic Eye Pain Market Drivers
2.3.3 Neuropathic Eye Pain Market Challenges
2.3.4 Neuropathic Eye Pain Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neuropathic Eye Pain Players by Revenue
3.1.1 Global Top Neuropathic Eye Pain Players by Revenue (2020-2025)
3.1.2 Global Neuropathic Eye Pain Revenue Market Share by Players (2020-2025)
3.2 Global Neuropathic Eye Pain Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Neuropathic Eye Pain Revenue
3.4 Global Neuropathic Eye Pain Market Concentration Ratio
3.4.1 Global Neuropathic Eye Pain Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neuropathic Eye Pain Revenue in 2024
3.5 Global Key Players of Neuropathic Eye Pain Head office and Area Served
3.6 Global Key Players of Neuropathic Eye Pain, Product and Application
3.7 Global Key Players of Neuropathic Eye Pain, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Neuropathic Eye Pain Breakdown Data by Type
4.1 Global Neuropathic Eye Pain Historic Market Size by Type (2020-2025)
4.2 Global Neuropathic Eye Pain Forecasted Market Size by Type (2026-2031)
5 Neuropathic Eye Pain Breakdown Data by Application
5.1 Global Neuropathic Eye Pain Historic Market Size by Application (2020-2025)
5.2 Global Neuropathic Eye Pain Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Neuropathic Eye Pain Market Size (2020-2031)
6.2 North America Neuropathic Eye Pain Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Neuropathic Eye Pain Market Size by Country (2020-2025)
6.4 North America Neuropathic Eye Pain Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Neuropathic Eye Pain Market Size (2020-2031)
7.2 Europe Neuropathic Eye Pain Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Neuropathic Eye Pain Market Size by Country (2020-2025)
7.4 Europe Neuropathic Eye Pain Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Neuropathic Eye Pain Market Size (2020-2031)
8.2 Asia-Pacific Neuropathic Eye Pain Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Neuropathic Eye Pain Market Size by Region (2020-2025)
8.4 Asia-Pacific Neuropathic Eye Pain Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Neuropathic Eye Pain Market Size (2020-2031)
9.2 Latin America Neuropathic Eye Pain Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Neuropathic Eye Pain Market Size by Country (2020-2025)
9.4 Latin America Neuropathic Eye Pain Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neuropathic Eye Pain Market Size (2020-2031)
10.2 Middle East & Africa Neuropathic Eye Pain Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Neuropathic Eye Pain Market Size by Country (2020-2025)
10.4 Middle East & Africa Neuropathic Eye Pain Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 OKYO Pharma
11.1.1 OKYO Pharma Company Details
11.1.2 OKYO Pharma Business Overview
11.1.3 OKYO Pharma Neuropathic Eye Pain Introduction
11.1.4 OKYO Pharma Revenue in Neuropathic Eye Pain Business (2020-2025)
11.1.5 OKYO Pharma Recent Development
11.2 Ocular Therapeutix, Inc.
11.2.1 Ocular Therapeutix, Inc. Company Details
11.2.2 Ocular Therapeutix, Inc. Business Overview
11.2.3 Ocular Therapeutix, Inc. Neuropathic Eye Pain Introduction
11.2.4 Ocular Therapeutix, Inc. Revenue in Neuropathic Eye Pain Business (2020-2025)
11.2.5 Ocular Therapeutix, Inc. Recent Development
11.3 IACTA Pharmaceuticals, Inc.
11.3.1 IACTA Pharmaceuticals, Inc. Company Details
11.3.2 IACTA Pharmaceuticals, Inc. Business Overview
11.3.3 IACTA Pharmaceuticals, Inc. Neuropathic Eye Pain Introduction
11.3.4 IACTA Pharmaceuticals, Inc. Revenue in Neuropathic Eye Pain Business (2020-2025)
11.3.5 IACTA Pharmaceuticals, Inc. Recent Development
11.4 Sun Pharmaceutical Industries Ltd
11.4.1 Sun Pharmaceutical Industries Ltd Company Details
11.4.2 Sun Pharmaceutical Industries Ltd Business Overview
11.4.3 Sun Pharmaceutical Industries Ltd Neuropathic Eye Pain Introduction
11.4.4 Sun Pharmaceutical Industries Ltd Revenue in Neuropathic Eye Pain Business (2020-2025)
11.4.5 Sun Pharmaceutical Industries Ltd Recent Development
11.5 Novartis AG
11.5.1 Novartis AG Company Details
11.5.2 Novartis AG Business Overview
11.5.3 Novartis AG Neuropathic Eye Pain Introduction
11.5.4 Novartis AG Revenue in Neuropathic Eye Pain Business (2020-2025)
11.5.5 Novartis AG Recent Development
11.6 SALVAT
11.6.1 SALVAT Company Details
11.6.2 SALVAT Business Overview
11.6.3 SALVAT Neuropathic Eye Pain Introduction
11.6.4 SALVAT Revenue in Neuropathic Eye Pain Business (2020-2025)
11.6.5 SALVAT Recent Development
11.7 AbbVie Inc
11.7.1 AbbVie Inc Company Details
11.7.2 AbbVie Inc Business Overview
11.7.3 AbbVie Inc Neuropathic Eye Pain Introduction
11.7.4 AbbVie Inc Revenue in Neuropathic Eye Pain Business (2020-2025)
11.7.5 AbbVie Inc Recent Development
11.8 Bausch &Lomb Incorporated
11.8.1 Bausch &Lomb Incorporated Company Details
11.8.2 Bausch &Lomb Incorporated Business Overview
11.8.3 Bausch &Lomb Incorporated Neuropathic Eye Pain Introduction
11.8.4 Bausch &Lomb Incorporated Revenue in Neuropathic Eye Pain Business (2020-2025)
11.8.5 Bausch &Lomb Incorporated Recent Development
11.9 Kala Pharmaceuticals
11.9.1 Kala Pharmaceuticals Company Details
11.9.2 Kala Pharmaceuticals Business Overview
11.9.3 Kala Pharmaceuticals Neuropathic Eye Pain Introduction
11.9.4 Kala Pharmaceuticals Revenue in Neuropathic Eye Pain Business (2020-2025)
11.9.5 Kala Pharmaceuticals Recent Development
11.10 Spectra Vision Care
11.10.1 Spectra Vision Care Company Details
11.10.2 Spectra Vision Care Business Overview
11.10.3 Spectra Vision Care Neuropathic Eye Pain Introduction
11.10.4 Spectra Vision Care Revenue in Neuropathic Eye Pain Business (2020-2025)
11.10.5 Spectra Vision Care Recent Development
11.11 AlconLaboratories
11.11.1 AlconLaboratories Company Details
11.11.2 AlconLaboratories Business Overview
11.11.3 AlconLaboratories Neuropathic Eye Pain Introduction
11.11.4 AlconLaboratories Revenue in Neuropathic Eye Pain Business (2020-2025)
11.11.5 AlconLaboratories Recent Development
11.12 BRIM Biotechnology Inc
11.12.1 BRIM Biotechnology Inc Company Details
11.12.2 BRIM Biotechnology Inc Business Overview
11.12.3 BRIM Biotechnology Inc Neuropathic Eye Pain Introduction
11.12.4 BRIM Biotechnology Inc Revenue in Neuropathic Eye Pain Business (2020-2025)
11.12.5 BRIM Biotechnology Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neuropathic Eye Pain Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Steroids
1.2.3 Antidepressants
1.2.4 Anticonvulsants
1.2.5 Opioids
1.2.6 Others
1.3 Market by Application
1.3.1 Global Neuropathic Eye Pain Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Neuropathic Eye Pain Market Perspective (2020-2031)
2.2 Global Neuropathic Eye Pain Growth Trends by Region
2.2.1 Global Neuropathic Eye Pain Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Neuropathic Eye Pain Historic Market Size by Region (2020-2025)
2.2.3 Neuropathic Eye Pain Forecasted Market Size by Region (2026-2031)
2.3 Neuropathic Eye Pain Market Dynamics
2.3.1 Neuropathic Eye Pain Industry Trends
2.3.2 Neuropathic Eye Pain Market Drivers
2.3.3 Neuropathic Eye Pain Market Challenges
2.3.4 Neuropathic Eye Pain Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neuropathic Eye Pain Players by Revenue
3.1.1 Global Top Neuropathic Eye Pain Players by Revenue (2020-2025)
3.1.2 Global Neuropathic Eye Pain Revenue Market Share by Players (2020-2025)
3.2 Global Neuropathic Eye Pain Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Neuropathic Eye Pain Revenue
3.4 Global Neuropathic Eye Pain Market Concentration Ratio
3.4.1 Global Neuropathic Eye Pain Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neuropathic Eye Pain Revenue in 2024
3.5 Global Key Players of Neuropathic Eye Pain Head office and Area Served
3.6 Global Key Players of Neuropathic Eye Pain, Product and Application
3.7 Global Key Players of Neuropathic Eye Pain, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Neuropathic Eye Pain Breakdown Data by Type
4.1 Global Neuropathic Eye Pain Historic Market Size by Type (2020-2025)
4.2 Global Neuropathic Eye Pain Forecasted Market Size by Type (2026-2031)
5 Neuropathic Eye Pain Breakdown Data by Application
5.1 Global Neuropathic Eye Pain Historic Market Size by Application (2020-2025)
5.2 Global Neuropathic Eye Pain Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Neuropathic Eye Pain Market Size (2020-2031)
6.2 North America Neuropathic Eye Pain Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Neuropathic Eye Pain Market Size by Country (2020-2025)
6.4 North America Neuropathic Eye Pain Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Neuropathic Eye Pain Market Size (2020-2031)
7.2 Europe Neuropathic Eye Pain Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Neuropathic Eye Pain Market Size by Country (2020-2025)
7.4 Europe Neuropathic Eye Pain Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Neuropathic Eye Pain Market Size (2020-2031)
8.2 Asia-Pacific Neuropathic Eye Pain Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Neuropathic Eye Pain Market Size by Region (2020-2025)
8.4 Asia-Pacific Neuropathic Eye Pain Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Neuropathic Eye Pain Market Size (2020-2031)
9.2 Latin America Neuropathic Eye Pain Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Neuropathic Eye Pain Market Size by Country (2020-2025)
9.4 Latin America Neuropathic Eye Pain Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neuropathic Eye Pain Market Size (2020-2031)
10.2 Middle East & Africa Neuropathic Eye Pain Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Neuropathic Eye Pain Market Size by Country (2020-2025)
10.4 Middle East & Africa Neuropathic Eye Pain Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 OKYO Pharma
11.1.1 OKYO Pharma Company Details
11.1.2 OKYO Pharma Business Overview
11.1.3 OKYO Pharma Neuropathic Eye Pain Introduction
11.1.4 OKYO Pharma Revenue in Neuropathic Eye Pain Business (2020-2025)
11.1.5 OKYO Pharma Recent Development
11.2 Ocular Therapeutix, Inc.
11.2.1 Ocular Therapeutix, Inc. Company Details
11.2.2 Ocular Therapeutix, Inc. Business Overview
11.2.3 Ocular Therapeutix, Inc. Neuropathic Eye Pain Introduction
11.2.4 Ocular Therapeutix, Inc. Revenue in Neuropathic Eye Pain Business (2020-2025)
11.2.5 Ocular Therapeutix, Inc. Recent Development
11.3 IACTA Pharmaceuticals, Inc.
11.3.1 IACTA Pharmaceuticals, Inc. Company Details
11.3.2 IACTA Pharmaceuticals, Inc. Business Overview
11.3.3 IACTA Pharmaceuticals, Inc. Neuropathic Eye Pain Introduction
11.3.4 IACTA Pharmaceuticals, Inc. Revenue in Neuropathic Eye Pain Business (2020-2025)
11.3.5 IACTA Pharmaceuticals, Inc. Recent Development
11.4 Sun Pharmaceutical Industries Ltd
11.4.1 Sun Pharmaceutical Industries Ltd Company Details
11.4.2 Sun Pharmaceutical Industries Ltd Business Overview
11.4.3 Sun Pharmaceutical Industries Ltd Neuropathic Eye Pain Introduction
11.4.4 Sun Pharmaceutical Industries Ltd Revenue in Neuropathic Eye Pain Business (2020-2025)
11.4.5 Sun Pharmaceutical Industries Ltd Recent Development
11.5 Novartis AG
11.5.1 Novartis AG Company Details
11.5.2 Novartis AG Business Overview
11.5.3 Novartis AG Neuropathic Eye Pain Introduction
11.5.4 Novartis AG Revenue in Neuropathic Eye Pain Business (2020-2025)
11.5.5 Novartis AG Recent Development
11.6 SALVAT
11.6.1 SALVAT Company Details
11.6.2 SALVAT Business Overview
11.6.3 SALVAT Neuropathic Eye Pain Introduction
11.6.4 SALVAT Revenue in Neuropathic Eye Pain Business (2020-2025)
11.6.5 SALVAT Recent Development
11.7 AbbVie Inc
11.7.1 AbbVie Inc Company Details
11.7.2 AbbVie Inc Business Overview
11.7.3 AbbVie Inc Neuropathic Eye Pain Introduction
11.7.4 AbbVie Inc Revenue in Neuropathic Eye Pain Business (2020-2025)
11.7.5 AbbVie Inc Recent Development
11.8 Bausch &Lomb Incorporated
11.8.1 Bausch &Lomb Incorporated Company Details
11.8.2 Bausch &Lomb Incorporated Business Overview
11.8.3 Bausch &Lomb Incorporated Neuropathic Eye Pain Introduction
11.8.4 Bausch &Lomb Incorporated Revenue in Neuropathic Eye Pain Business (2020-2025)
11.8.5 Bausch &Lomb Incorporated Recent Development
11.9 Kala Pharmaceuticals
11.9.1 Kala Pharmaceuticals Company Details
11.9.2 Kala Pharmaceuticals Business Overview
11.9.3 Kala Pharmaceuticals Neuropathic Eye Pain Introduction
11.9.4 Kala Pharmaceuticals Revenue in Neuropathic Eye Pain Business (2020-2025)
11.9.5 Kala Pharmaceuticals Recent Development
11.10 Spectra Vision Care
11.10.1 Spectra Vision Care Company Details
11.10.2 Spectra Vision Care Business Overview
11.10.3 Spectra Vision Care Neuropathic Eye Pain Introduction
11.10.4 Spectra Vision Care Revenue in Neuropathic Eye Pain Business (2020-2025)
11.10.5 Spectra Vision Care Recent Development
11.11 AlconLaboratories
11.11.1 AlconLaboratories Company Details
11.11.2 AlconLaboratories Business Overview
11.11.3 AlconLaboratories Neuropathic Eye Pain Introduction
11.11.4 AlconLaboratories Revenue in Neuropathic Eye Pain Business (2020-2025)
11.11.5 AlconLaboratories Recent Development
11.12 BRIM Biotechnology Inc
11.12.1 BRIM Biotechnology Inc Company Details
11.12.2 BRIM Biotechnology Inc Business Overview
11.12.3 BRIM Biotechnology Inc Neuropathic Eye Pain Introduction
11.12.4 BRIM Biotechnology Inc Revenue in Neuropathic Eye Pain Business (2020-2025)
11.12.5 BRIM Biotechnology Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Neuropathic Eye Pain Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Steroids
Table 3. Key Players of Antidepressants
Table 4. Key Players of Anticonvulsants
Table 5. Key Players of Opioids
Table 6. Key Players of Others
Table 7. Global Neuropathic Eye Pain Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Neuropathic Eye Pain Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Neuropathic Eye Pain Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Neuropathic Eye Pain Market Share by Region (2020-2025)
Table 11. Global Neuropathic Eye Pain Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Neuropathic Eye Pain Market Share by Region (2026-2031)
Table 13. Neuropathic Eye Pain Market Trends
Table 14. Neuropathic Eye Pain Market Drivers
Table 15. Neuropathic Eye Pain Market Challenges
Table 16. Neuropathic Eye Pain Market Restraints
Table 17. Global Neuropathic Eye Pain Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Neuropathic Eye Pain Market Share by Players (2020-2025)
Table 19. Global Top Neuropathic Eye Pain Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuropathic Eye Pain as of 2024)
Table 20. Ranking of Global Top Neuropathic Eye Pain Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Neuropathic Eye Pain Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Neuropathic Eye Pain, Headquarters and Area Served
Table 23. Global Key Players of Neuropathic Eye Pain, Product and Application
Table 24. Global Key Players of Neuropathic Eye Pain, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Neuropathic Eye Pain Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Neuropathic Eye Pain Revenue Market Share by Type (2020-2025)
Table 28. Global Neuropathic Eye Pain Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Neuropathic Eye Pain Revenue Market Share by Type (2026-2031)
Table 30. Global Neuropathic Eye Pain Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Neuropathic Eye Pain Revenue Market Share by Application (2020-2025)
Table 32. Global Neuropathic Eye Pain Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Neuropathic Eye Pain Revenue Market Share by Application (2026-2031)
Table 34. North America Neuropathic Eye Pain Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Neuropathic Eye Pain Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Neuropathic Eye Pain Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Neuropathic Eye Pain Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Neuropathic Eye Pain Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Neuropathic Eye Pain Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Neuropathic Eye Pain Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Neuropathic Eye Pain Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Neuropathic Eye Pain Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Neuropathic Eye Pain Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Neuropathic Eye Pain Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Neuropathic Eye Pain Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Neuropathic Eye Pain Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Neuropathic Eye Pain Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Neuropathic Eye Pain Market Size by Country (2026-2031) & (US$ Million)
Table 49. OKYO Pharma Company Details
Table 50. OKYO Pharma Business Overview
Table 51. OKYO Pharma Neuropathic Eye Pain Product
Table 52. OKYO Pharma Revenue in Neuropathic Eye Pain Business (2020-2025) & (US$ Million)
Table 53. OKYO Pharma Recent Development
Table 54. Ocular Therapeutix, Inc. Company Details
Table 55. Ocular Therapeutix, Inc. Business Overview
Table 56. Ocular Therapeutix, Inc. Neuropathic Eye Pain Product
Table 57. Ocular Therapeutix, Inc. Revenue in Neuropathic Eye Pain Business (2020-2025) & (US$ Million)
Table 58. Ocular Therapeutix, Inc. Recent Development
Table 59. IACTA Pharmaceuticals, Inc. Company Details
Table 60. IACTA Pharmaceuticals, Inc. Business Overview
Table 61. IACTA Pharmaceuticals, Inc. Neuropathic Eye Pain Product
Table 62. IACTA Pharmaceuticals, Inc. Revenue in Neuropathic Eye Pain Business (2020-2025) & (US$ Million)
Table 63. IACTA Pharmaceuticals, Inc. Recent Development
Table 64. Sun Pharmaceutical Industries Ltd Company Details
Table 65. Sun Pharmaceutical Industries Ltd Business Overview
Table 66. Sun Pharmaceutical Industries Ltd Neuropathic Eye Pain Product
Table 67. Sun Pharmaceutical Industries Ltd Revenue in Neuropathic Eye Pain Business (2020-2025) & (US$ Million)
Table 68. Sun Pharmaceutical Industries Ltd Recent Development
Table 69. Novartis AG Company Details
Table 70. Novartis AG Business Overview
Table 71. Novartis AG Neuropathic Eye Pain Product
Table 72. Novartis AG Revenue in Neuropathic Eye Pain Business (2020-2025) & (US$ Million)
Table 73. Novartis AG Recent Development
Table 74. SALVAT Company Details
Table 75. SALVAT Business Overview
Table 76. SALVAT Neuropathic Eye Pain Product
Table 77. SALVAT Revenue in Neuropathic Eye Pain Business (2020-2025) & (US$ Million)
Table 78. SALVAT Recent Development
Table 79. AbbVie Inc Company Details
Table 80. AbbVie Inc Business Overview
Table 81. AbbVie Inc Neuropathic Eye Pain Product
Table 82. AbbVie Inc Revenue in Neuropathic Eye Pain Business (2020-2025) & (US$ Million)
Table 83. AbbVie Inc Recent Development
Table 84. Bausch &Lomb Incorporated Company Details
Table 85. Bausch &Lomb Incorporated Business Overview
Table 86. Bausch &Lomb Incorporated Neuropathic Eye Pain Product
Table 87. Bausch &Lomb Incorporated Revenue in Neuropathic Eye Pain Business (2020-2025) & (US$ Million)
Table 88. Bausch &Lomb Incorporated Recent Development
Table 89. Kala Pharmaceuticals Company Details
Table 90. Kala Pharmaceuticals Business Overview
Table 91. Kala Pharmaceuticals Neuropathic Eye Pain Product
Table 92. Kala Pharmaceuticals Revenue in Neuropathic Eye Pain Business (2020-2025) & (US$ Million)
Table 93. Kala Pharmaceuticals Recent Development
Table 94. Spectra Vision Care Company Details
Table 95. Spectra Vision Care Business Overview
Table 96. Spectra Vision Care Neuropathic Eye Pain Product
Table 97. Spectra Vision Care Revenue in Neuropathic Eye Pain Business (2020-2025) & (US$ Million)
Table 98. Spectra Vision Care Recent Development
Table 99. AlconLaboratories Company Details
Table 100. AlconLaboratories Business Overview
Table 101. AlconLaboratories Neuropathic Eye Pain Product
Table 102. AlconLaboratories Revenue in Neuropathic Eye Pain Business (2020-2025) & (US$ Million)
Table 103. AlconLaboratories Recent Development
Table 104. BRIM Biotechnology Inc Company Details
Table 105. BRIM Biotechnology Inc Business Overview
Table 106. BRIM Biotechnology Inc Neuropathic Eye Pain Product
Table 107. BRIM Biotechnology Inc Revenue in Neuropathic Eye Pain Business (2020-2025) & (US$ Million)
Table 108. BRIM Biotechnology Inc Recent Development
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
Table 112. Authors List of This Report
List of Figures
Figure 1. Neuropathic Eye Pain Picture
Figure 2. Global Neuropathic Eye Pain Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Neuropathic Eye Pain Market Share by Type: 2024 VS 2031
Figure 4. Steroids Features
Figure 5. Antidepressants Features
Figure 6. Anticonvulsants Features
Figure 7. Opioids Features
Figure 8. Others Features
Figure 9. Global Neuropathic Eye Pain Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Neuropathic Eye Pain Market Share by Application: 2024 VS 2031
Figure 11. Clinic Case Studies
Figure 12. Hospital Case Studies
Figure 13. Others Case Studies
Figure 14. Neuropathic Eye Pain Report Years Considered
Figure 15. Global Neuropathic Eye Pain Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Neuropathic Eye Pain Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Neuropathic Eye Pain Market Share by Region: 2024 VS 2031
Figure 18. Global Neuropathic Eye Pain Market Share by Players in 2024
Figure 19. Global Top Neuropathic Eye Pain Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuropathic Eye Pain as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Neuropathic Eye Pain Revenue in 2024
Figure 21. North America Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Neuropathic Eye Pain Market Share by Country (2020-2031)
Figure 23. United States Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Neuropathic Eye Pain Market Share by Country (2020-2031)
Figure 27. Germany Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Neuropathic Eye Pain Market Share by Region (2020-2031)
Figure 35. China Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Neuropathic Eye Pain Market Share by Country (2020-2031)
Figure 43. Mexico Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Neuropathic Eye Pain Market Share by Country (2020-2031)
Figure 47. Turkey Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. OKYO Pharma Revenue Growth Rate in Neuropathic Eye Pain Business (2020-2025)
Figure 51. Ocular Therapeutix, Inc. Revenue Growth Rate in Neuropathic Eye Pain Business (2020-2025)
Figure 52. IACTA Pharmaceuticals, Inc. Revenue Growth Rate in Neuropathic Eye Pain Business (2020-2025)
Figure 53. Sun Pharmaceutical Industries Ltd Revenue Growth Rate in Neuropathic Eye Pain Business (2020-2025)
Figure 54. Novartis AG Revenue Growth Rate in Neuropathic Eye Pain Business (2020-2025)
Figure 55. SALVAT Revenue Growth Rate in Neuropathic Eye Pain Business (2020-2025)
Figure 56. AbbVie Inc Revenue Growth Rate in Neuropathic Eye Pain Business (2020-2025)
Figure 57. Bausch &Lomb Incorporated Revenue Growth Rate in Neuropathic Eye Pain Business (2020-2025)
Figure 58. Kala Pharmaceuticals Revenue Growth Rate in Neuropathic Eye Pain Business (2020-2025)
Figure 59. Spectra Vision Care Revenue Growth Rate in Neuropathic Eye Pain Business (2020-2025)
Figure 60. AlconLaboratories Revenue Growth Rate in Neuropathic Eye Pain Business (2020-2025)
Figure 61. BRIM Biotechnology Inc Revenue Growth Rate in Neuropathic Eye Pain Business (2020-2025)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Global Neuropathic Eye Pain Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Steroids
Table 3. Key Players of Antidepressants
Table 4. Key Players of Anticonvulsants
Table 5. Key Players of Opioids
Table 6. Key Players of Others
Table 7. Global Neuropathic Eye Pain Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Neuropathic Eye Pain Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Neuropathic Eye Pain Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Neuropathic Eye Pain Market Share by Region (2020-2025)
Table 11. Global Neuropathic Eye Pain Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Neuropathic Eye Pain Market Share by Region (2026-2031)
Table 13. Neuropathic Eye Pain Market Trends
Table 14. Neuropathic Eye Pain Market Drivers
Table 15. Neuropathic Eye Pain Market Challenges
Table 16. Neuropathic Eye Pain Market Restraints
Table 17. Global Neuropathic Eye Pain Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Neuropathic Eye Pain Market Share by Players (2020-2025)
Table 19. Global Top Neuropathic Eye Pain Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuropathic Eye Pain as of 2024)
Table 20. Ranking of Global Top Neuropathic Eye Pain Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Neuropathic Eye Pain Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Neuropathic Eye Pain, Headquarters and Area Served
Table 23. Global Key Players of Neuropathic Eye Pain, Product and Application
Table 24. Global Key Players of Neuropathic Eye Pain, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Neuropathic Eye Pain Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Neuropathic Eye Pain Revenue Market Share by Type (2020-2025)
Table 28. Global Neuropathic Eye Pain Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Neuropathic Eye Pain Revenue Market Share by Type (2026-2031)
Table 30. Global Neuropathic Eye Pain Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Neuropathic Eye Pain Revenue Market Share by Application (2020-2025)
Table 32. Global Neuropathic Eye Pain Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Neuropathic Eye Pain Revenue Market Share by Application (2026-2031)
Table 34. North America Neuropathic Eye Pain Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Neuropathic Eye Pain Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Neuropathic Eye Pain Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Neuropathic Eye Pain Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Neuropathic Eye Pain Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Neuropathic Eye Pain Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Neuropathic Eye Pain Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Neuropathic Eye Pain Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Neuropathic Eye Pain Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Neuropathic Eye Pain Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Neuropathic Eye Pain Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Neuropathic Eye Pain Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Neuropathic Eye Pain Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Neuropathic Eye Pain Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Neuropathic Eye Pain Market Size by Country (2026-2031) & (US$ Million)
Table 49. OKYO Pharma Company Details
Table 50. OKYO Pharma Business Overview
Table 51. OKYO Pharma Neuropathic Eye Pain Product
Table 52. OKYO Pharma Revenue in Neuropathic Eye Pain Business (2020-2025) & (US$ Million)
Table 53. OKYO Pharma Recent Development
Table 54. Ocular Therapeutix, Inc. Company Details
Table 55. Ocular Therapeutix, Inc. Business Overview
Table 56. Ocular Therapeutix, Inc. Neuropathic Eye Pain Product
Table 57. Ocular Therapeutix, Inc. Revenue in Neuropathic Eye Pain Business (2020-2025) & (US$ Million)
Table 58. Ocular Therapeutix, Inc. Recent Development
Table 59. IACTA Pharmaceuticals, Inc. Company Details
Table 60. IACTA Pharmaceuticals, Inc. Business Overview
Table 61. IACTA Pharmaceuticals, Inc. Neuropathic Eye Pain Product
Table 62. IACTA Pharmaceuticals, Inc. Revenue in Neuropathic Eye Pain Business (2020-2025) & (US$ Million)
Table 63. IACTA Pharmaceuticals, Inc. Recent Development
Table 64. Sun Pharmaceutical Industries Ltd Company Details
Table 65. Sun Pharmaceutical Industries Ltd Business Overview
Table 66. Sun Pharmaceutical Industries Ltd Neuropathic Eye Pain Product
Table 67. Sun Pharmaceutical Industries Ltd Revenue in Neuropathic Eye Pain Business (2020-2025) & (US$ Million)
Table 68. Sun Pharmaceutical Industries Ltd Recent Development
Table 69. Novartis AG Company Details
Table 70. Novartis AG Business Overview
Table 71. Novartis AG Neuropathic Eye Pain Product
Table 72. Novartis AG Revenue in Neuropathic Eye Pain Business (2020-2025) & (US$ Million)
Table 73. Novartis AG Recent Development
Table 74. SALVAT Company Details
Table 75. SALVAT Business Overview
Table 76. SALVAT Neuropathic Eye Pain Product
Table 77. SALVAT Revenue in Neuropathic Eye Pain Business (2020-2025) & (US$ Million)
Table 78. SALVAT Recent Development
Table 79. AbbVie Inc Company Details
Table 80. AbbVie Inc Business Overview
Table 81. AbbVie Inc Neuropathic Eye Pain Product
Table 82. AbbVie Inc Revenue in Neuropathic Eye Pain Business (2020-2025) & (US$ Million)
Table 83. AbbVie Inc Recent Development
Table 84. Bausch &Lomb Incorporated Company Details
Table 85. Bausch &Lomb Incorporated Business Overview
Table 86. Bausch &Lomb Incorporated Neuropathic Eye Pain Product
Table 87. Bausch &Lomb Incorporated Revenue in Neuropathic Eye Pain Business (2020-2025) & (US$ Million)
Table 88. Bausch &Lomb Incorporated Recent Development
Table 89. Kala Pharmaceuticals Company Details
Table 90. Kala Pharmaceuticals Business Overview
Table 91. Kala Pharmaceuticals Neuropathic Eye Pain Product
Table 92. Kala Pharmaceuticals Revenue in Neuropathic Eye Pain Business (2020-2025) & (US$ Million)
Table 93. Kala Pharmaceuticals Recent Development
Table 94. Spectra Vision Care Company Details
Table 95. Spectra Vision Care Business Overview
Table 96. Spectra Vision Care Neuropathic Eye Pain Product
Table 97. Spectra Vision Care Revenue in Neuropathic Eye Pain Business (2020-2025) & (US$ Million)
Table 98. Spectra Vision Care Recent Development
Table 99. AlconLaboratories Company Details
Table 100. AlconLaboratories Business Overview
Table 101. AlconLaboratories Neuropathic Eye Pain Product
Table 102. AlconLaboratories Revenue in Neuropathic Eye Pain Business (2020-2025) & (US$ Million)
Table 103. AlconLaboratories Recent Development
Table 104. BRIM Biotechnology Inc Company Details
Table 105. BRIM Biotechnology Inc Business Overview
Table 106. BRIM Biotechnology Inc Neuropathic Eye Pain Product
Table 107. BRIM Biotechnology Inc Revenue in Neuropathic Eye Pain Business (2020-2025) & (US$ Million)
Table 108. BRIM Biotechnology Inc Recent Development
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
Table 112. Authors List of This Report
List of Figures
Figure 1. Neuropathic Eye Pain Picture
Figure 2. Global Neuropathic Eye Pain Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Neuropathic Eye Pain Market Share by Type: 2024 VS 2031
Figure 4. Steroids Features
Figure 5. Antidepressants Features
Figure 6. Anticonvulsants Features
Figure 7. Opioids Features
Figure 8. Others Features
Figure 9. Global Neuropathic Eye Pain Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Neuropathic Eye Pain Market Share by Application: 2024 VS 2031
Figure 11. Clinic Case Studies
Figure 12. Hospital Case Studies
Figure 13. Others Case Studies
Figure 14. Neuropathic Eye Pain Report Years Considered
Figure 15. Global Neuropathic Eye Pain Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Neuropathic Eye Pain Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Neuropathic Eye Pain Market Share by Region: 2024 VS 2031
Figure 18. Global Neuropathic Eye Pain Market Share by Players in 2024
Figure 19. Global Top Neuropathic Eye Pain Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuropathic Eye Pain as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Neuropathic Eye Pain Revenue in 2024
Figure 21. North America Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Neuropathic Eye Pain Market Share by Country (2020-2031)
Figure 23. United States Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Neuropathic Eye Pain Market Share by Country (2020-2031)
Figure 27. Germany Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Neuropathic Eye Pain Market Share by Region (2020-2031)
Figure 35. China Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Neuropathic Eye Pain Market Share by Country (2020-2031)
Figure 43. Mexico Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Neuropathic Eye Pain Market Share by Country (2020-2031)
Figure 47. Turkey Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Neuropathic Eye Pain Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. OKYO Pharma Revenue Growth Rate in Neuropathic Eye Pain Business (2020-2025)
Figure 51. Ocular Therapeutix, Inc. Revenue Growth Rate in Neuropathic Eye Pain Business (2020-2025)
Figure 52. IACTA Pharmaceuticals, Inc. Revenue Growth Rate in Neuropathic Eye Pain Business (2020-2025)
Figure 53. Sun Pharmaceutical Industries Ltd Revenue Growth Rate in Neuropathic Eye Pain Business (2020-2025)
Figure 54. Novartis AG Revenue Growth Rate in Neuropathic Eye Pain Business (2020-2025)
Figure 55. SALVAT Revenue Growth Rate in Neuropathic Eye Pain Business (2020-2025)
Figure 56. AbbVie Inc Revenue Growth Rate in Neuropathic Eye Pain Business (2020-2025)
Figure 57. Bausch &Lomb Incorporated Revenue Growth Rate in Neuropathic Eye Pain Business (2020-2025)
Figure 58. Kala Pharmaceuticals Revenue Growth Rate in Neuropathic Eye Pain Business (2020-2025)
Figure 59. Spectra Vision Care Revenue Growth Rate in Neuropathic Eye Pain Business (2020-2025)
Figure 60. AlconLaboratories Revenue Growth Rate in Neuropathic Eye Pain Business (2020-2025)
Figure 61. BRIM Biotechnology Inc Revenue Growth Rate in Neuropathic Eye Pain Business (2020-2025)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Cutting Machines for Diamond Market Research Report 2025
Jul 18, 25
Global RF Shielded Enclosures Market Research Report 2025
Jul 18, 25
Global Padel Court Market Research Report 2025
Jul 18, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232